FDA Approved: CINACALCET — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s supplemental application for cinacalcet under ANDA 208915. The approval authorizes the continued marketing of the generic cinacalc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia Due to Parathyroid Carcinoma
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

SUPPL AP for CINACALCET (CINACALCET)